StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Protagenic Therapeutics, Inc.new's market cap was $1.36M on Oct 19, 2026, against $1.33M a year earlier. Over the last 5 years it ranged from $93.11K to $31.88M, with a median of $4.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.36M+101.9%
2025Dec 31, 2025$672.43K-71.4%
2024Dec 31, 2024$2.35M-45.1%
2023Dec 29, 2023$4.29M-38.0%
2022Dec 30, 2022$6.91M-70.6%
2021Dec 31, 2021$23.48M–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?